Inflammopharmacology

Foreword
pp. 157-158(2)

Pharmacological implications in the switch from acute to chronic inflammation
pp. 159-171(13)
Authors: Dallegri F.; Ottonello L.

Effects of oxaprozin and of other 2-arylpropionic acid derivatives on nuclear factor B(NF-B) activation
pp. 173-183(11)
Author: Bevilacqua M.

Recent pharmacodynamic and pharmacokinetic findings on oxaprozin
pp. 185-239(55)
Authors: Rainsford K.D.; Omar H.; Ashraf A.; Hewson A.T.; Bunning R.A.D.; Rishiraj R.; Shepherd P.; Seabrook R.W.

A critical assessment of oxaprozin clinical profile in rheumatic diseases
pp. 241-284(44)
Authors: Kean W.F.; Kean R.; Buchanan W.W.

Alan Bennett, 8 March 1936-16 May 2002
pp. 285-288(4)
Author: Rainsford K.D.

Announcement
pp. 289-289(1)